Amylyx Pharmaceuticals, Inc. AMLX Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s other income (expense)?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported other income (expense) of $2.5M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s other income (expense) changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s other income (expense) increased by 31.6% year-over-year, from $1.9M to $2.5M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s other income (expense) has grown at a 13.2% compound annual growth rate (CAGR), from -$5.24M to $8.6M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.